{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:23:16Z","timestamp":1782307396726,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN 64285"],"award-info":[{"award-number":["FRN 64285"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Ottawa Tier 1 and Tier 2 Research Chair Award","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Children's Hospital of Eastern Ontario Departments of Pediatrics and Surgery","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Children's Hospital of Eastern Ontario Research Institute","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11914-021-00667-x","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T07:21:05Z","timestamp":1625901665000},"page":"278-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Part I: Which Child with a Chronic Disease Needs Bone Health Monitoring?"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1557-9185","authenticated-orcid":false,"given":"Leanne M.","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,10]]},"reference":[{"issue":"7","key":"667_CR1","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00198-016-3515-9","volume":"27","author":"LM Ward","year":"2016","unstructured":"Ward LM, Konji VN, Ma J. The management of osteoporosis in children. Osteoporos Int. 2016;27(7):2147\u201379.","journal-title":"Osteoporos Int"},{"issue":"4","key":"667_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11914-017-0371-2","volume":"15","author":"M Grover","year":"2017","unstructured":"Grover M, Bachrach LK. Osteoporosis in children with chronic illnesses: diagnosis, monitoring, and treatment. Curr Osteoporos Rep. 2017;15(4):271\u201382.","journal-title":"Curr Osteoporos Rep"},{"issue":"11","key":"667_CR3","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1210\/jc.2015-2680","volume":"100","author":"S George","year":"2015","unstructured":"George S, Weber DR, Kaplan P, Hummel K, Monk HM, Levine MA. Short-term safety of zoledronic acid in young patients with bone disorders: an extensive institutional experience. J Clin Endocrinol Metab. 2015;100(11):4163\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"667_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bone.2019.01.003","volume":"121","author":"N Nasomyont","year":"2019","unstructured":"Nasomyont N, Hornung LN, Gordon CM, Wasserman H. Outcomes following intravenous bisphosphonate infusion in pediatric patients: a 7-year retrospective chart review. Bone. 2019;121:60\u20137.","journal-title":"Bone"},{"key":"667_CR5","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3389\/fendo.2020.00576","volume":"11","author":"LM Ward","year":"2020","unstructured":"Ward LM. Glucocorticoid-induced osteoporosis: why kids are different. Front Endocrinol (Lausanne). 2020;11:576.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"667_CR6","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1359\/jbmr.090202","volume":"24","author":"J Halton","year":"2009","unstructured":"Halton J, Gaboury I, Grant R, Alos N, Cummings EA, Matzinger M, et al. Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res. 2009;24(7):1326\u201334.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"667_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/acr.20171","volume":"62","author":"AM Huber","year":"2010","unstructured":"Huber AM, Gaboury I, Cabral DA, Lang B, Ni A, Stephure D, et al. Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res. 2010;62(4):516\u201326.","journal-title":"Arthritis Care Res"},{"issue":"6","key":"667_CR8","first-page":"2122","volume":"85","author":"M Thearle","year":"2000","unstructured":"Thearle M, Horlick M, Bilezikian JP, Levy J, Gertner JM, Levine LS, et al. Osteoporosis: an unusual presentation of childhood Crohn\u2019s disease. J Clin Endocrinol Metab. 2000;85(6):2122\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"667_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11914-018-0468-2","volume":"16","author":"A Boulanger Piette","year":"2018","unstructured":"Boulanger Piette A, Hamoudi D, Marcadet L, Morin F, Argaw A, Ward L, et al. Targeting the muscle-bone unit: filling two needs with one deed in the treatment of duchenne muscular dystrophy. Curr Osteoporos Rep. 2018;16(5):541\u201353.","journal-title":"Curr Osteoporos Rep"},{"key":"667_CR10","doi-asserted-by":"crossref","unstructured":"Lorenzo J. Cytokines and bone: osteoimmunology. Handb Exp Pharmacol. 2020;262:177\u2013230.","DOI":"10.1007\/164_2019_346"},{"issue":"8","key":"667_CR11","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/jbmr.3447","volume":"33","author":"LM Ward","year":"2018","unstructured":"Ward LM, Ma J, Lang B, Ho J, Alos N, Matzinger MA, et al. Bone morbidity and recovery in children with acute lymphoblastic leukemia: results of a six-year prospective cohort study. J Bone Miner Res. 2018;33(8):1435\u201343.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"667_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/jamaneurol.2019.0242","volume":"76","author":"S Joseph","year":"2019","unstructured":"Joseph S, Wang C, Bushby K, Guglieri M, Horrocks I, Straub V, et al. Fractures and linear growth in a nationwide cohort of boys with Duchenne muscular dystrophy with and without glucocorticoid treatment: results from the UK NorthStar Database. JAMA Neurol. 2019;76(6):701\u20139.","journal-title":"JAMA Neurol"},{"issue":"9","key":"667_CR13","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/jbmr.2511","volume":"30","author":"CM LeBlanc","year":"2015","unstructured":"LeBlanc CM, Ma J, Taljaard M, Roth J, Scuccimarri R, Miettunen P, et al. Incident vertebral fractures and risk factors in the first three years following glucocorticoid initiation among pediatric patients with rheumatic disorders. J Bone Miner Res. 2015;30(9):1667\u201375.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"667_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00198-013-2466-7","volume":"25","author":"V Phan","year":"2014","unstructured":"Phan V, Blydt-Hansen T, Feber J, Alos N, Arora S, Atkinson S, et al. Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome. Osteoporos Int. 2014;25(2):627\u201337.","journal-title":"Osteoporos Int"},{"issue":"2","key":"667_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1152\/physrev.00011.2015","volume":"96","author":"K Hartmann","year":"2016","unstructured":"Hartmann K, Koenen M, Schauer S, Wittig-Blaich S, Ahmad M, Baschant U, et al. Molecular actions of glucocorticoids in cartilage and bone during health, disease, and steroid therapy. Physiol Rev. 2016;96(2):409\u201347.","journal-title":"Physiol Rev"},{"key":"667_CR16","doi-asserted-by":"crossref","unstructured":"Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children. J Pediatr. 1979;95(2):239\u201343.","DOI":"10.1016\/S0022-3476(79)80658-7"},{"issue":"3","key":"667_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1203\/00006450-200109000-00003","volume":"50","author":"F Rauch","year":"2001","unstructured":"Rauch F, Schoenau E. The developing bone: slave or master of its cells and molecules? Pediatr Res. 2001;50(3):309\u201314.","journal-title":"Pediatr Res"},{"issue":"2","key":"667_CR18","first-page":"73","volume":"2","author":"HM Frost","year":"1987","unstructured":"Frost HM. The mechanostat: a proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. Bone Miner. 1987;2(2):73\u201385.","journal-title":"Bone Miner"},{"issue":"6","key":"667_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1515\/JPEM.2000.13.6.571","volume":"13","author":"HM Frost","year":"2000","unstructured":"Frost HM, Schonau E. The \u201cmuscle-bone unit\u201d in children and adolescents: a 2000 overview. J Pediatr Endocrinol Metab. 2000;13(6):571\u201390.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"667_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00198-016-3774-5","volume":"28","author":"J Ma","year":"2017","unstructured":"Ma J, McMillan HJ, Karaguzel G, Goodin C, Wasson J, Matzinger MA, et al. The time to and determinants of first fractures in boys with Duchenne muscular dystrophy. Osteoporos Int. 2017;28(2):597\u2013608.","journal-title":"Osteoporos Int"},{"issue":"12","key":"667_CR21","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1359\/jbmr.040902","volume":"19","author":"C Cooper","year":"2004","unstructured":"Cooper C, Dennison EM, Leufkens HG, Bishop N, van Staa TP. Epidemiology of childhood fractures in Britain: a study using the general practice research database. J Bone Miner Res. 2004;19(12):1976\u201381.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"667_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s11914-014-0227-y","volume":"12","author":"EM Clark","year":"2014","unstructured":"Clark EM. The epidemiology of fractures in otherwise healthy children. Curr Osteoporos Rep. 2014;12(3):272\u20138.","journal-title":"Curr Osteoporos Rep"},{"issue":"12","key":"667_CR23","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1002\/jbmr.155","volume":"25","author":"MK Mayranpaa","year":"2010","unstructured":"Mayranpaa MK, Makitie O, Kallio PE. Decreasing incidence and changing pattern of childhood fractures: a population-based study. J Bone Miner Res. 2010;25(12):2752\u20139.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"667_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jocd.2014.01.004","volume":"17","author":"N Bishop","year":"2014","unstructured":"Bishop N, Arundel P, Clark E, Dimitri P, Farr J, Jones G, et al. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric Official Positions. J Clin Densitom. 2014;17(2):275\u201380.","journal-title":"J Clin Densitom"},{"issue":"1","key":"667_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jocd.2007.12.002","volume":"11","author":"S Baim","year":"2008","unstructured":"Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB, et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom. 2008;11(1):6\u201321.","journal-title":"J Clin Densitom"},{"issue":"2 Pt 1","key":"667_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0022-3476(99)70020-X","volume":"135","author":"MB Leonard","year":"1999","unstructured":"Leonard MB, Propert KJ, Zemel BS, Stallings VA, Feldman HI. Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. J Pediatr. 1999;135(2 Pt 1):182\u20138.","journal-title":"J Pediatr"},{"issue":"10","key":"667_CR27","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1210\/jc.2010-0677","volume":"95","author":"J Kocks","year":"2010","unstructured":"Kocks J, Ward K, Mughal Z, Moncayo R, Adams J, Hogler W. Z-score comparability of bone mineral density reference databases for children. J Clin Endocrinol Metab. 2010;95(10):4652\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"667_CR28","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1210\/jc.2014-3096","volume":"100","author":"J Ma","year":"2015","unstructured":"Ma J, Siminoski K, Alos N, Halton J, Ho J, Lentle B, et al. The choice of normative pediatric reference database changes spine bone mineral density Z-scores but not the relationship between bone mineral density and prevalent vertebral fractures. J Clin Endocrinol Metab. 2015;100(3):1018\u201327.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"667_CR29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00223-018-0449-6","volume":"103","author":"M Fiscaletti","year":"2018","unstructured":"Fiscaletti M, Coorey CP, Biggin A, Briody J, Little DG, Schindeler A, et al. Diagnosis of recurrent fracture in a pediatric cohort. Calcif Tissue Int. 2018;103(5):529\u201339.","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"667_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/acr.20589","volume":"64","author":"C Rodd","year":"2012","unstructured":"Rodd C, Lang B, Ramsay T, Alos N, Huber AM, Cabral DA, et al. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res. 2012;64(1):122\u201331.","journal-title":"Arthritis Care Res"},{"issue":"5","key":"667_CR31","doi-asserted-by":"publisher","first-page":"e2088","DOI":"10.1210\/clinem\/dgz294","volume":"105","author":"LM Ward","year":"2020","unstructured":"Ward LM, Weber DR, Munns CF, Hogler W, Zemel BS. A contemporary view of the definition and diagnosis of osteoporosis in children and adolescents. J Clin Endocrinol Metab. 2020;105(5):e2088\u201397.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"667_CR32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.ecl.2020.07.005","volume":"49","author":"LM Ward","year":"2020","unstructured":"Ward LM, Konji VN. Advances in the bone health assessment of children. Endocrinol Metab Clin N Am. 2020;49(4):613\u201336.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"11","key":"667_CR33","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1007\/s00198-017-4159-0","volume":"28","author":"LM Ward","year":"2017","unstructured":"Ward LM, Ma J, Rauch F, Benchimol EI, Hay J, Leonard MB, et al. Musculoskeletal health in newly diagnosed children with Crohn\u2019s disease. Osteoporos Int. 2017;28(11):3169\u201377.","journal-title":"Osteoporos Int"},{"issue":"3","key":"667_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1469-8749.2009.03464.x","volume":"52","author":"P Kilpinen-Loisa","year":"2010","unstructured":"Kilpinen-Loisa P, Paasio T, Soiva M, Ritanen UM, Lautala P, Palmu P, et al. Low bone mass in patients with motor disability: prevalence and risk factors in 59 Finnish children. Dev Med Child Neurol. 2010;52(3):276\u201382.","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"667_CR35","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137\u201348.","journal-title":"J Bone Miner Res"},{"issue":"7","key":"667_CR36","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/jbmr.5650110716","volume":"11","author":"HK Genant","year":"1996","unstructured":"Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1996;11(7):984\u201396.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"667_CR37","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00247-014-3210-y","volume":"45","author":"JL Jaremko","year":"2015","unstructured":"Jaremko JL, Siminoski K, Firth GB, Matzinger MA, Shenouda N, Konji VN, et al. Common normal variants of pediatric vertebral development that mimic fractures: a pictorial review from a national longitudinal bone health study. Pediatr Radiol. 2015;45(4):593\u2013605.","journal-title":"Pediatr Radiol"},{"key":"667_CR38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jpeds.2016.08.075","volume":"179","author":"A Kyriakou","year":"2016","unstructured":"Kyriakou A, Shepherd S, Mason A, Ahmed SF. Prevalence of vertebral fractures in children with suspected osteoporosis. J Pediatr. 2016;179:219\u201325.","journal-title":"J Pediatr"},{"key":"667_CR39","doi-asserted-by":"crossref","unstructured":"Singh A, Schaeffer EK, Reilly CW. Vertebral fractures in Duchenne muscular dystrophy patients managed with deflazacort. J Pediatr Orthop. 2018; 38(6):320\u20134.","DOI":"10.1097\/BPO.0000000000000817"},{"issue":"1","key":"667_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.semarthrit.2014.02.002","volume":"44","author":"KE Hansen","year":"2014","unstructured":"Hansen KE, Kleker B, Safdar N, Bartels CM. A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children. Semin Arthritis Rheum. 2014;44(1):47\u201354.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"667_CR41","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00198-011-1621-2","volume":"23","author":"J Feber","year":"2012","unstructured":"Feber J, Gaboury I, Ni A, Alos N, Arora S, Bell L, et al. Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome. Osteoporos Int. 2012;23(2):751\u201360.","journal-title":"Osteoporos Int"},{"issue":"22","key":"667_CR42","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1200\/JCO.2011.40.4830","volume":"30","author":"N Alos","year":"2012","unstructured":"Alos N, Grant RM, Ramsay T, Halton J, Cummings EA, Miettunen PM, et al. High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. J Clin Oncol. 2012;30(22):2760\u20137.","journal-title":"J Clin Oncol"},{"issue":"9","key":"667_CR43","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1210\/JC.2015-2176","volume":"100","author":"EA Cummings","year":"2015","unstructured":"Cummings EA, Ma J, Fernandez CV, Halton J, Alos N, Miettunen PM, et al. Incident vertebral fractures in children with leukemia during the four years following diagnosis. J Clin Endocrinol Metab. 2015;100(9):3408\u201317.","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"667_CR44","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1212\/01.wnl.0000260974.41514.83","volume":"68","author":"WM King","year":"2007","unstructured":"King WM, Ruttencutter R, Nagaraja HN, Matkovic V, Landoll J, Hoyle C, et al. Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology. 2007;68(19):1607\u201313.","journal-title":"Neurology"},{"issue":"1","key":"667_CR45","first-page":"71","volume":"20","author":"CM Larson","year":"2000","unstructured":"Larson CM, Henderson RC. Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop. 2000;20(1):71\u20134.","journal-title":"J Pediatr Orthop"},{"issue":"3","key":"667_CR46","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/jbmr.3922","volume":"35","author":"J Ma","year":"2020","unstructured":"Ma J, Siminoski K, Wang P, Alos N, Cummings EA, Feber J, et al. The accuracy of prevalent vertebral fracture detection in children using targeted case-finding approaches. J Bone Miner Res. 2020;35(3):460\u20138.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"667_CR47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/jbmr.3589","volume":"34","author":"A Kelly","year":"2019","unstructured":"Kelly A, Shults J, Mostoufi-Moab S, McCormack SE, Stallings VA, Schall JI, et al. Pediatric bone mineral accrual Z-score calculation equations and their application in childhood disease. J Bone Miner Res. 2019;34(1):195\u2013203.","journal-title":"J Bone Miner Res"},{"key":"667_CR48","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jocd.2019.07.002","volume":"22","author":"DR Weber","year":"2019","unstructured":"Weber DR, Boyce A, Gordon C, Hogler W, Kecskemethy HH, Misra M, et al. The utility of DXA assessment at the forearm, proximal femur, and lateral distal femur, and vertebral fracture assessment in the pediatric population: the 2019 Official Pediatric Positions of the ISCD. J Clin Densitom. 2019;22:567\u201389.","journal-title":"J Clin Densitom"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-021-00667-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-021-00667-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-021-00667-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T07:35:03Z","timestamp":1627112103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-021-00667-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["667"],"URL":"https:\/\/doi.org\/10.1007\/s11914-021-00667-x","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"12 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Ward has participated in clinical trials with ReveraGen BioPharma, PTC Therapeutics, Catabasis Pharmaceuticals, Novartis, and Amgen. Dr. Ward has also received consulting fees from PTC Therapeutics, Novartis and Amgen, with funds to the Children\u2019s Hospital of Eastern Ontario Research Institute.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any original studies with human or animal subjects performed by the author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}